XENIA PHARMA ApS: Financial statements 2019
CVR: 35529454
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
XENIA PHARMA ApS (CVR 35529454) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -3,399 and a net result of DKK -3,449 compared with DKK -24,939 the year before. Equity in the 2019 report amounted to DKK 789. The solvency ratio was 1.9%.
- Gross Profit
- DKK -3,399
- Profit/Loss
- DKK -3,449
- Equity
- DKK 789
- Total Assets
- DKK 42,505
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -3K | -3K | 789 | - |
| 2018 | - | -25K | -25K | 4K | - |
| 2017 | - | -3K | -3K | 29K | - |
| 2016 | - | -47K | -47K | 33K | 0 |
| 2015 | 103K | 31K | 23K | 80K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
XENIA PHARMA ApS has published its annual report for 2018. Gross profit came to DKK -24,920, and the net result was DKK -24,939.
About XENIA PHARMA ApS
XENIA PHARMA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2013. The company is registered under the industry Dyrlægeaktiviteter. The management consists of Dorte Xenia Gram. The company is owned by Dorte Xenia Gram. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -28,827 and a net result of DKK -28,855 compared with DKK -18,952 the year before. Equity in the 2025 report amounted to DKK -46,501.